Â鶹ѧÉú¾«Æ·°æ

Eileen Hwang
( out of 168 reviews )

Eileen Hwang, MD, PhD

Languages spoken: English

Clinical Locations

John A. Moran Eye Center

Salt Lake City
801-581-2352

Primary Children's Hospital

Salt Lake City
801-662-1000

Redstone Health Center

Park City
435-658-9200

Redwood Health Center

Salt Lake City
801-213-9900

South Jordan Health Center

South Jordan
801-213-4500

  • Eileen Hwang, MD, PhD, specializes in the medical and surgical treatment of children and adults with retina conditions such as age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusions, myopic degeneration, macular hole, epiretinal membrane, retinal tears, retinal detachment, retinopathy of prematurity, Sticklers syndrome, Coats disease, familial exudative vitreoretinopathy, and traumatic eye injury.

    Dr. Hwang received her bachelor’s degree in physics from Princeton University and her doctorate and medical degree at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. She completed her ophthalmology residency at the John A. Moran Eye Center at the University of Utah. She went on to finish a two-year fellowship in vitreoretinal surgery at the Medical College of Wisconsin, where she performed lensectomy, vitrectomy, scleral buckles, lasers, and injections in infants, children, and adults.

    As a , Dr. Hwang has a proven track record of publications and independent research funding, including a Knights Templar Foundation (KTEF) Career-Starter Research Grant, being accepted into the University of Utah’s Vice President’s Clinical & Translational (VPCAT) Research Scholars Program, and receiving the VitreoRetinal Surgery Foundation Research Award, the Randall J Olson Scholar Award from the Achievement Rewards for College Scientists (ARCS) Foundation, and an F30 fellowship from the National Institutes of Health – National Institute of Diabetes and Digestive and Kidney Diseases.

    Get to know Dr. Hwang by watching her .

    Specialties

    Board Certification

    American Board of Ophthalmology

    Patient Rating

    4.8 /5
    ( out of 168 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Grossman is an amazing provider and one that I have been seeing for over 14 years. I feel very confident I am in good hands and that he truly cares about me and my skin cancer condition. I would recommend him to anyone who wants a provider that treats them with respect and really listens to your concerns.

    August 22, 2024
    HUNTSMAN CANCER CENTER

    Dr. Grossman is an outstanding provider who is very invested in his patients. Always willing to explain treatment options.

    August 18, 2024
    HUNTSMAN CANCER CENTER

    Marianne is the most sincere caring healthcare professional I have come across. She truly cares how you feel about yourself. She explains everything so you totally understand and takes your concerns very seriously. She is the best.

    August 18, 2024
    HUNTSMAN CANCER CENTER

    I love Marianne , she is very nice, very professional and has a wonderful sense of humor.

    August 15, 2024
    HUNTSMAN CANCER CENTER

    Dr Grossman is the best of the best. His manner is thorough and informative. With his little magic magnifying glass he can scan my body in minutes and pick up any potential problems I may have that require further investigation. As a teacher he is masterful with his medical students showing them how to differentiate between areas that need attention and those that are merely age related. A+ every time for Dr. Grossman.

    August 09, 2024
    HUNTSMAN CANCER CENTER

    Have great faith in this Doctor

    August 02, 2024
    HUNTSMAN CANCER CENTER

    Marianne is the best. Highly recommended.

    July 28, 2024
    SOUTH JORDAN HEALTH CENTER

    Dr Hwang is very compasionate and concerned for any conditions that might be happening, she explains the options thouroughly, I trust her skills and knowledge.

    July 14, 2024
    SOUTH JORDAN HEALTH CENTER

    She. Is very cordial and efficient.

    See More Patient Comments

  • Eileen Hwang, MD, PhD, specializes in the medical and surgical treatment of children and adults with retina conditions such as age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusions, myopic degeneration, macular hole, epiretinal membrane, retinal tears, retinal detachment, retinopathy of prematurity, Sticklers syndrome, Coats disease, familial exudative vitreoretinopathy, and traumatic eye injury.

    Dr. Hwang received her bachelor’s degree in physics from Princeton University and her doctorate and medical degree at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. She completed her ophthalmology residency at the John A. Moran Eye Center at the University of Utah. She went on to finish a two-year fellowship in vitreoretinal surgery at the Medical College of Wisconsin, where she performed lensectomy, vitrectomy, scleral buckles, lasers, and injections in infants, children, and adults.

    As a , Dr. Hwang has a proven track record of publications and independent research funding, including a Knights Templar Foundation (KTEF) Career-Starter Research Grant, being accepted into the University of Utah’s Vice President’s Clinical & Translational (VPCAT) Research Scholars Program, and receiving the VitreoRetinal Surgery Foundation Research Award, the Randall J Olson Scholar Award from the Achievement Rewards for College Scientists (ARCS) Foundation, and an F30 fellowship from the National Institutes of Health – National Institute of Diabetes and Digestive and Kidney Diseases.

    Get to know Dr. Hwang by watching her .

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Board Certification
    American Board of Ophthalmology

    Education history

    Fellowship Vitreoretinal Surgery - Medical College of Wisconsin Fellow
    Ophthalmology - University of Utah School of Medicine, John A. Moran Eye Center Resident
    Internship Preliminary Internal Medicine - Ophthalmology - University of Utah School of Medicine Intern
    Biochemistry and Molecular Biology - University of Medicine and Dentistry of New Jersey, Graduate School of Biomedical Sciences Ph.D.
    Professional Medical Medicine - University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School M.D.
    Physics - Princeton University B.A.

    Selected Publications

    Journal Article

    1. Hwang ES, Harrie RP, Desautels J (2023). Bilateral Cataracts and Posterior Lentiglobus in USP9X Syndrome. Ophthalmology. ()
    2. Hwang ES, Liu L, Ong MY, Rodriguez CM, Schwehr DE, Sanchez DE, Stoddard GJ, Weinberg DV (2022). Self-reporting of conflicts of interest by ophthalmology researchers compared to the Open Payments Database industry reports. . Ophthalmology, 130(4), 387-393. ()
    3. Elizabeth C Koller, Jessica A Kraker, Eileen S Hwang (2021). Progression of partial posterior vitreous detachment over time. Retina, 41(7), 1396-1402.
    4. Randerson EL, Bogaard JD, Koenig LR, Hwang ES, Warren CC, Koenig SB (2020). Clinical Outcomes and Lens Constant Optimization of the Zeiss CT Lucia 602 Lens Using a Modified Yamane Technique. Clin Ophthalmol, 14, 3903-3912. ()
    5. Kraker JA, Kim JE, Koller EC, George JC, Hwang ES (2020). Standard 6 mm Compared to Wide Field 16.5 mm Optical Coherence Tomography for Staging of Posterior Vitreous Detachment. Ophthalmol Retina, 4(11), 1093-1102.
    6. Hwang ES, Kraker JA, Griffin KJ, Sebag J, Weinberg DV, Kim JE (2019). Accuracy of spectral domain optical coherence tomography of the macula for detection of complete posterior vitreous detachment. Ophthalmol Retina, 4(2), 148-153.
    7. Hwang ES, Morgan DJ, Pennington KL, Owen LA, Fingert JH, Bernstein PS, DeAngelis MM (2019). Progressive optic nerve changes in cavitary optic disc anomaly: integration of copy number alteration and cis-expression quantitative trait loci to assess disease etiology. BMC Med Genet, 20(1), 63. ()
    8. Bee CR, Koenig LR, Hwang ES, Koenig SB (2018). Removal of calcific band keratopathy without ethylenediaminetetraacetic acid (EDTA) in eyes with limited visual potential. Clin Ophthalmol, 12, 1895-1899. ()
    9. Hwang ES, Stagg BC, Swan R, Fenzl CR, McFadden M, Muthappan V, Santiago-Caban L, Mifflin MD, Moshirfar M (2017). Corneal biomechanical properties after laser-assisted in situ keratomileusis and photorefractive keratectomy. Clin Ophthalmol, 11, 1785-1789. ()
    10. Hwang ES, Brodsky B (2012). Folding delay and structural perturbations caused by type IV collagen natural interruptions and nearby Gly missense mutations. J Biol Chem, 287(6), 4368-75. ()
    11. Cheng H, Rashid S, Yu Z, Yoshizumi A, Hwang E, Brodsky B (2011). Location of glycine mutations within a bacterial collagen protein affects degree of disruption of triple-helix folding and conformation. J Biol Chem, 286(3), 2041-6. ()
    12. Hwang ES, Thiagarajan G, Parmar AS, Brodsky B (2010). Interruptions in the collagen repeating tripeptide pattern can promote supramolecular association. Protein Sci, 19(5), 1053-64. ()

    Review

    1. Phillips JD, Hwang ES, Morgan DJ, Creveling CJ, Coats B (2022). Structure and mechanics of the vitreoretinal interface. [Review]. J Mech Behav Biomed Mater, 134, 105399. ()

    Case Report

    1. Sophie R, Moses GM, Hwang ES, Kim JE (2019). Fundus hypopigmentation and loss of choroidal nevi pigmentation associated with nivolumab. JAMA Ophthalmol, 137(7), 851-3.
    2. Hwang ES, Bell JE, Quigley EP, Hoesch RE, Shakoor A (2018). Stroke Due to Cerebral Vasculitis in a Patient with Relentless Placoid Chorioretinitis. Ocul Immunol Inflamm, 26(6), 921.